EBD Group is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Asthika Goonewardene is the senior biotechnology analyst with Bloomberg Intelligence, a unique research platform that provides context on industries, companies, and government policy, available on the Bloomberg Professional Service at BI <GO>. Mr. Goonewardene leads coverage of the global biotech. Prior to this role, Mr. Goonewardene was based in Europe, covering the large cap pharmaceutical and generics sector.
Mr. Goonewardene has more than a decade of experience in research and analysis within the pharmaceuticals industry, working at firms such as Johnson & Johnson, OSI Pharmaceuticals and Piper Jaffray. Prior to joining Bloomberg in 2011, Mr. Goonewardene worked as a senior consultant at Datamonitor, advising pharmaceutical companies on lifecycle management strategies and assessing market opportunities for both blockbuster and specialty drugs.
In his roles at Bloomberg Intelligence, Mr. Goonewardene has lead a series of seminars, webinars and panel discussion on topics such as advances in immuno-oncology, deal-making, biosimilars, pricing and reimbursement, emerging market strategies, and tax inversion in the pharmaceutical sector.
Mr. Goonewardene holds a BS in Biotechnology and an MBA in Marketing, Technology Management from Rochester Institute of Technology.